COVID-19 has become less of an urgent threat than it was in 2019 largely because of vaccines and growing immunity from natural infections, but antiviral treatments have also changed the course of the ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Paxlovid is an antiviral that treats COVID-19, says Linda Yancey, M.D., an infectious diseases specialist ...

NEW YORK -- When Laura Martin tested positive for COVID-19 last month during an extended stay in California, she was prescribed Paxlovid, the highly touted antiviral drug created by Pfizer. Just one ...

Earlier this year, hospitals eagerly embraced findings that the antiviral drug Paxlovid ™, also known as Niratrelvir-ritonavir, could battle severe COVID-19 symptoms. A study found that a five-day ...

One in five people who take nirmatrelvir/ritonavir (Paxlovid) get COVID-19 again after the drug clears them of it, according to a new study. For reference, people who didn’t take ...

A new study by investigators from Mass General Brigham found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, ...

Paxlovid helps prevent severe COVID-19, but it also might significantly increase a person's risk of a rebound case, a new study confirms. About 1 in 5 people taking Paxlovid recovered and tested ...

An observational study of patients being treated for acute COVID-19 in a multicenter health care system observed virologic rebound in about 20 percent of patients treated with nirmatrelvir-ritonavir ...